There are no products listed under this category.
CHST13
CHST13 (carbohydrate sulfotransferase 13, also known as C4ST3) is a Golgi membrane enzyme that transfers sulfate to position 4 of N-acetylgalactosamine residues in chondroitin. It contributes to the sulfation of chondroitin sulfate, the predominant proteoglycan of cartilage. Browse Assay Genie's current range of CHST13 research reagents below, or read on for the biology behind the target.
CHST13 catalyses the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Its specificity is defined: it transfers sulfate to the C4 hydroxyl of beta-1,4-linked GalNAc that is substituted with a beta-linked glucuronic acid at the C-3 hydroxyl. UniProt reports no activity toward dermatan, which distinguishes its substrate preference from that of other sulfotransferases acting on related glycosaminoglycans.
Chondroitin sulfate is the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and within extracellular matrices. Sulfation of the chondroitin chain by enzymes such as CHST13 is therefore a point of interest for researchers studying matrix composition and cell-surface glycosaminoglycans.
The CHST13 protein belongs to the sulfotransferase 2 family and is classed by HGNC in the group of membrane-bound sulfotransferases. It is localised to the Golgi apparatus membrane, where glycosaminoglycan modification takes place. The enzyme carries the EC number 2.8.2.5. The gene was previously named carbohydrate (chondroitin 4) sulfotransferase 13, and C4ST3 remains a common alias. Related family members such as CHST9 are also studied in the context of carbohydrate sulfation.
CHST13 acts on chondroitin, making it a useful subject for studies of how sulfation patterns are built on glycosaminoglycan chains.
Chondroitin sulfate is the predominant proteoglycan in cartilage, so CHST13 is relevant to work on extracellular matrix composition.
As a Golgi membrane sulfotransferase, CHST13 supports research into where and how carbohydrate modifications are added during glycan processing.
CHST13 acts on beta-linked GalNAc flanked by glucuronic acid and not on dermatan, offering a clear model of substrate selectivity.
CHST13 is a Golgi-resident sulfotransferase that catalyses transfer of sulfate to the C4 hydroxyl of beta-1,4-linked N-acetylgalactosamine in chondroitin, where the GalNAc is flanked by glucuronic acid. It shows no activity toward dermatan.
CHST13 stands for carbohydrate sulfotransferase 13. Its alias is C4ST3, and its previous HGNC name was carbohydrate (chondroitin 4) sulfotransferase 13. The enzyme is classified as EC 2.8.2.5 and belongs to the sulfotransferase 2 family.
UniProt and NCBI Gene both place CHST13 at the Golgi apparatus membrane. This fits its role in modifying chondroitin, a component of proteoglycans found in cartilage and on cell surfaces and extracellular matrices.
Other carbohydrate sulfotransferases and glycosaminoglycan-modifying enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8NET6; product specifications from Assay Genie datasheets.
There are no products listed under this category.